AYTU BIOPHARMA, INC Quarterly General and Administrative Expense in USD from Q4 2010 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Aytu Biopharma, Inc quarterly/annual General and Administrative Expense history and growth rate from Q4 2010 to Q3 2024.
- Aytu Biopharma, Inc General and Administrative Expense for the quarter ending September 30, 2024 was $5.13M, a 18.6% decline year-over-year.
- Aytu Biopharma, Inc General and Administrative Expense for the twelve months ending September 30, 2024 was $21.3M, a 22.7% decline year-over-year.
- Aytu Biopharma, Inc annual General and Administrative Expense for 2024 was $22.5M, a 21.4% decline from 2023.
- Aytu Biopharma, Inc annual General and Administrative Expense for 2023 was $28.6M, a 8.14% decline from 2022.
- Aytu Biopharma, Inc annual General and Administrative Expense for 2022 was $31.2M, a 22.2% increase from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)